Which Region Held A Maximum Shares In The Immunohistochemistry Market?
Immunohistochemistry (IHC) refers
to an important application monoclonal and polyclonal antibodies for tissue
determination and distribution of antigens of particular disease. The
applications for immunohistochemistry includes detection several infectious
disorders like dengue, hepatitis, human immunodeficiency virus (HIV). Chronic
medical conditions such as cancer, obesity, diabetes, heart disease, and
stroke, are also considered to be the primary major applications of immunohistochemistry
that helps in the diagnosis of these diseases. Increasing incidences of
infectious diseases such as HIV is the primary global public health issue.
Download Sample Copy Here
 |
Immunohistochemistry |
Immunohistochemistry (IHC) is the most common application of immunostaining.
The emerging markets in the countries of Asia Pacific are creating significant opportunities for the key market players to expand their business. It is likely to be a prime factor contributing to the market growth during the coming years. Majority of the players concentrate on developing markets such as India and China, owing to the large population suffering from chronic diseases in these countries. With rising costs of production against their practices, the healthcare companies are striving to produce sufficient revenue to entertain their investors.
The Major Operating Players
Danaher
Merck KGaA
Thermo Fisher Scientific, Inc.
PerkinElmer, Inc.
Abcam Plc
Agilent Technologies
Bio SB
Bio-Rad Laboratories, Inc
Cell Signalling Technology, Inc.
F. Hoffmann-La Roche Ltd.
Comments
Post a Comment